Low dose environmental radon exposure and breast tumor gene expression.

Abstract:

BACKGROUND:The International Agency for Research on Cancer classified radon and its decay-products as Group-1-human-carcinogens, and with the current knowledge they are linked specifically to lung cancer. Biokinetic models predict that radon could deliver a carcinogenic dose to breast tissue. Our previous work suggested that low-dose radon was associated with estrogen-receptor (ER)-negative breast cancer risk. However, there is limited research to examine the role of radon in breast cancer biology at the tissue level. We aim to understand molecular pathways linking radon exposure with breast cancer biology using transcriptome-wide-gene-expression from breast tumor and normal-adjacent tissues. METHODS:Our study included 943 women diagnosed with breast cancer from the Nurses' Health Study (NHS) and NHSII. We estimated cumulative radon concentration for each participant up-to the year of breast cancer diagnosis by linking residential addresses with a radon exposure model. Transcriptome-wide-gene-expression was measured with the Affymetrix-Glue-Human-Transcriptome-Array-3.0 and Human-Transcriptome-Array-2.0. We performed covariate-adjusted linear-regression for individual genes and further employed pathway-analysis. All analyses were conducted separately for tumor and normal-adjacent samples and by ER-status. RESULTS:No individual gene was associated with cumulative radon exposure in ER-positive tumor, ER-negative tumor, or ER-negative normal-adjacent tissues at FDR < 5%. In ER-positive normal-adjacent samples, PLCH2-reached transcriptome-wide-significance (FDR < 5%). Gene-set-enrichment-analyses identified 2-upregulated pathways (MAPK signaling and phosphocholine biosynthesis) enriched at FDR < 25% in ER-negative tumors and normal-adjacent tissues, and both pathways have been previously reported to play key roles in ionizing radiation induced tumorigenesis in experimental settings. CONCLUSION:Our findings provide insights into the molecular pathways of radon exposure that may influence breast cancer etiology.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Peng C,DuPre N,VoPham T,Heng YJ,Baker GM,Rubadue CA,Glass K,Sonawane A,Zeleznik O,Kraft P,Hankinson SE,Eliassen AH,Hart JE,Laden F,Tamimi RM

doi

10.1186/s12885-020-07184-7

subject

Has Abstract

pub_date

2020-07-28 00:00:00

pages

695

issue

1

issn

1471-2407

pii

10.1186/s12885-020-07184-7

journal_volume

20

pub_type

杂志文章
  • Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

    abstract:BACKGROUND:Advanced biliary tract carcinomas (BTCs) have poor prognosis and limited therapeutic options. Therefore, it is crucial to combine standard therapies with molecular targeting. In this study EGFR, HER2, and their molecular transducers were analysed in terms of mutations, amplifications and over-expression in a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-631

    authors: Pignochino Y,Sarotto I,Peraldo-Neia C,Penachioni JY,Cavalloni G,Migliardi G,Casorzo L,Chiorino G,Risio M,Bardelli A,Aglietta M,Leone F

    更新日期:2010-11-18 00:00:00

  • Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.

    abstract:BACKGROUND:The differentiation of pancreatic ductal adenocarcinoma (PDAC) could be associated with prognosis and may influence the choices of clinical management. No applicable methods could reliably predict the tumor differentiation preoperatively. Thus, the aim of this study was to compare the metabonomic profiling o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3703-9

    authors: Wen S,Zhan B,Feng J,Hu W,Lin X,Bai J,Huang H

    更新日期:2017-11-02 00:00:00

  • Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.

    abstract:BACKGROUND:To investigate the implications of prophylactic intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with D2 radical gastrectomy for locally advanced Gastric Cancer (AGC) in a randomized case control study. METHOD:Eighty consecutive patients with locally AGC were randomly separated into 2 groups...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6125-z

    authors: Beeharry MK,Zhu ZL,Liu WT,Yao XX,Yan M,Zhu ZG

    更新日期:2019-09-18 00:00:00

  • Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.

    abstract:BACKGROUND:Clinical characterization of bladder carcinomas is still inadequate using the standard clinico-pathological prognostic markers. We assessed the correlation between nm23-H1, Rb, EGFR and p53 in relation to the clinical outcome of patients with muscle invasive bilharzial bladder cancer (MI-BBC). METHODS:nm23-...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-32

    authors: Khaled HM,Bahnassy AA,Raafat AA,Zekri AR,Madboul MS,Mokhtar NM

    更新日期:2009-01-26 00:00:00

  • High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study.

    abstract:BACKGROUND:For metastatic spinal cord compression (MSCC), conventional radiotherapy with 10 × 3 Gy in 2 weeks results in better local progression-free survival (LPFS) than 5 × 4 Gy in 1 week. Since patients with MSCC are often significantly impaired, an overall treatment time of 1 week would be preferable if resulting ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3844-x

    authors: Rades D,Cacicedo J,Conde-Moreno AJ,Doemer C,Dunst J,Lomidze D,Segedin B,Olbrich D,Holländer NH

    更新日期:2017-12-04 00:00:00

  • ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.

    abstract:BACKGROUND:Kruppel family member zinc binding protein 89 (ZBP-89), also known as ZNF148, regulates Bak expression via binding to GC-rich promoter domain. It is not clear if other GC-rich binding factors, such as Sp family members, can interact with ZBPp-89 on Bak expression. This study aims to elucidate the mechanism o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4349-y

    authors: Kong X,Xu P,Cai WJ,Wang HG,Li BB,Huang GL,He ZW,Chen G,Ye CG

    更新日期:2018-04-13 00:00:00

  • Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (WJOG

    abstract:BACKGROUND:Bevacizumab, a humanized antibody to vascular endothelial growth factor (VEGF), shows clinical activity against human cancer, with its addition to standard chemotherapy having been found to improve outcome in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). However, there have been no e...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/1471-2407-12-327

    authors: Takeda M,Okamoto I,Yamanaka T,Nakagawa K,Nakanishi Y

    更新日期:2012-08-01 00:00:00

  • Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans.

    abstract:BACKGROUND:Gastric Helicobacter pylori (H. pylori) infection and colorectal polyps are more prevalent in African Americans than in the general population. We aimed to investigate whether gastric H. pylori infection is associated with colorectal polyps in African Americans. METHODS:Medical records of African Americans,...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-296

    authors: Brim H,Zahaf M,Laiyemo AO,Nouraie M,Pérez-Pérez GI,Smoot DT,Lee E,Razjouyan H,Ashktorab H

    更新日期:2014-04-28 00:00:00

  • VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) isoforms, particularly the diffusible VEGF-121, could play a major role in the response of recurrent glioblastoma (GB) to anti-angiogenetic treatment with bevacizumab. We hypothesized that circulating VEGF-121 may reduce the amount of bevacizumab available to target ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4442-2

    authors: Martini M,de Pascalis I,D'Alessandris QG,Fiorentino V,Pierconti F,Marei HE,Ricci-Vitiani L,Pallini R,Larocca LM

    更新日期:2018-05-10 00:00:00

  • Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases.

    abstract:BACKGROUND:Downstream of Ras, the serine/threonine kinase B-raf has been reported to be mutated, among other carcinomas, in a substantial subset of primary melanomas with a preponderance of mutations within the kinase domain including the activating V599E and V599K transitions. METHODS:We here investigated a represent...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-58

    authors: Deichmann M,Thome M,Benner A,Kirschner M,Hassanzadeh J,Kurzen H

    更新日期:2005-06-03 00:00:00

  • Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.

    abstract:BACKGROUND:Metformin is a biguanide oral hypoglycaemic agent commonly used for the treatment of type 2 diabetes mellitus. In addition to its anti-diabetic effect, metformin has also been associated with a reduced risk of cancer incidence of a number of solid tumours, including prostate cancer (PCa). However, the underl...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-017-3458-3

    authors: Crawley D,Chandra A,Loda M,Gillett C,Cathcart P,Challacombe B,Cook G,Cahill D,Santa Olalla A,Cahill F,George G,Rudman S,Van Hemelrijck M

    更新日期:2017-07-21 00:00:00

  • Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study.

    abstract:BACKGROUND:Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and to assess whether socioeconomic indicators were predictors of access at the leve...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4958-5

    authors: Scherpereel A,Durand-Zaleski I,Cotté FE,Fernandes J,Debieuvre D,Blein C,Gaudin AF,Tournier C,Vainchtock A,Chauvin P,Souquet PJ,Westeel V,Chouaïd C

    更新日期:2018-10-22 00:00:00

  • Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.

    abstract:BACKGROUND:There is increasing appreciation that non-cancer cells within the tumour microenvironment influence cancer progression and anti-cancer drug efficacy. For metastatic prostate cancer (PCa), the bone marrow microenvironment influences metastasis, drug response, and possibly drug resistance. METHODS:Using a nov...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4473-8

    authors: Mosaad E,Chambers K,Futrega K,Clements J,Doran MR

    更新日期:2018-05-24 00:00:00

  • Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines.

    abstract:BACKGROUND:Lactic acid bacteria (LAB) are beneficial probiotic organisms that contribute to improved nutrition, microbial balance, and immuno-enhancement of the intestinal tract, as well as anti-tumor activity. The aim of the present work was to study the growth inhibition of tumor cells by butanol extract of Bifidobac...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-310

    authors: Lee DK,Jang S,Kim MJ,Kim JH,Chung MJ,Kim KJ,Ha NJ

    更新日期:2008-10-27 00:00:00

  • Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer.

    abstract:BACKGROUND:There is evidence that some ovarian tumours evoke an immune response, which can be assessed by tumour infiltrating lymphocytes (TILs). To facilitate adoption of TILs as a clinical biomarker, a standardised method for their H&E visual evaluation has been validated in breast cancer. METHODS:We sought to inves...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3585-x

    authors: James FR,Jiminez-Linan M,Alsop J,Mack M,Song H,Brenton JD,Pharoah PDP,Ali HR

    更新日期:2017-09-20 00:00:00

  • The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies.

    abstract:BACKGROUND:The association between immune-related adverse events (irAEs) and survival outcomes in patients with advanced melanoma receiving therapy with immune checkpoint inhibitors (ICIs) has not been well established, particularly in Asian melanoma. METHODS:We retrospectively reviewed 49 melanoma patients undergoing...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07508-7

    authors: Wu CE,Yang CK,Peng MT,Huang PW,Chang CF,Yeh KY,Chen CB,Wang CL,Hsu CW,Chen IW,Lin CT,Ueng SH,Lin G,Lin YF,Cheng CY,Chang JW

    更新日期:2020-10-21 00:00:00

  • Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.

    abstract:BACKGROUND:The VEGF family of ligands and receptors are intimately involved in tumor angiogenesis, lymphangiogenesis and metastasis. The evaluation of VEGF ligand/receptor ratios may provide a more profound understanding of the involvement of these proteins in colorectal tumour progression. The aim of this study was to...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-93

    authors: Eppenberger M,Zlobec I,Baumhoer D,Terracciano L,Lugli A

    更新日期:2010-03-11 00:00:00

  • Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.

    abstract:BACKGROUND:Vinflunine is recommended in the European guideline for the treatment of advanced or metastatic urothelial cell carcinoma (UCC) after failure of platinum-based therapy. METHODS:This prospective, non-interventional study investigated the safety and efficacy of vinflunine in platinum-pretreated UCC patients i...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-015-1434-3

    authors: Retz M,de Geeter P,Goebell PJ,Matz U,de Schultz W,Hegele A

    更新日期:2015-06-04 00:00:00

  • Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study.

    abstract:BACKGROUND:Kidney and renal pelvis cancers account for 4% of all new cancer cases in the United States, among which 85% are renal cell carcinomas (RCC). While cigarette smoking is an established risk factor for RCC, little is known about the contribution of environmental tobacco smoke (ETS) to RCC incidence. This study...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-387

    authors: Theis RP,Dolwick Grieb SM,Burr D,Siddiqui T,Asal NR

    更新日期:2008-12-24 00:00:00

  • Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer.

    abstract:BACKGROUND:Pancreatic adenocarcinoma is one of the most dreaded cancers with very low survival rate and poor prognosis to the existing frontline chemotherapeutic drugs. Gene therapy in combination with a cytotoxic agent could be a promising approach to circumvent the limitations of previously attempted therapeutic inte...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-75

    authors: Xu J,Singh A,Amiji MM

    更新日期:2014-02-08 00:00:00

  • Constructions of sex and intimacy after cancer: Q methodology study of people with cancer, their partners, and health professionals.

    abstract:BACKGROUND:The increasing number of individuals living with cancer has led to a focus on the quality of life of survivors, and their families. Sexual wellbeing is a central component of quality of life, with a growing body of research demonstrating the association between cancer and changes to sexuality and intimacy. H...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-270

    authors: Perz J,Ussher JM,Gilbert E

    更新日期:2013-05-31 00:00:00

  • Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.

    abstract:BACKGROUND:Several stromal cell subtypes including macrophages contribute to tumor progression by inducing epithelial-mesenchymal transition (EMT) at the invasive front, a mechanism also linked to metastasis. Tumor associated macrophages (TAM) reside mainly at the invasive front but they also infiltrate tumors and in t...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-35

    authors: Bonde AK,Tischler V,Kumar S,Soltermann A,Schwendener RA

    更新日期:2012-01-24 00:00:00

  • Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells.

    abstract:BACKGROUND:c-Met signaling has been implicated in oncogenesis especially in cells with c-met gene amplification. Since 20 % of gastric cancer patients show high level of c-Met expression, c-Met has been identified as a good candidate for targeted therapy in gastric cancer. Herein, we report our newly synthesized c-Met ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2058-y

    authors: Park CH,Cho SY,Ha JD,Jung H,Kim HR,Lee CO,Jang IY,Chae CH,Lee HK,Choi SU

    更新日期:2016-01-22 00:00:00

  • A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.

    abstract:BACKGROUND:Cancer vaccine is one of the attractive treatment modalities for patients with castration-resistant prostate cancer (CRPC). However, because of delayed immune responses, its clinical benefits, besides for overall survival (OS), are not well captured by the World Health Organization (WHO) and Response Evaluat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-613

    authors: Noguchi M,Moriya F,Suekane S,Ohnishi R,Matsueda S,Sasada T,Yamada A,Itoh K

    更新日期:2013-12-30 00:00:00

  • EnROL: a multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme.

    abstract:BACKGROUND:During the last two decades the use of laparoscopic resection and a multimodal approach known as an enhanced recovery programme, have been major changes in colorectal perioperative care. Clinical outcome improves using laparoscopic surgery to resect colorectal cancer but until recently no multicentre trial e...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/1471-2407-12-181

    authors: Kennedy RH,Francis A,Dutton S,Love S,Pearson S,Blazeby JM,Quirke P,Franks PJ,Kerr DJ

    更新日期:2012-05-16 00:00:00

  • Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma.

    abstract:BACKGROUND:Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeutic effects. METHODS:This phase I study evaluated dose limiting toxicity (DLT...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-12-587

    authors: Mayr M,Becker K,Schulte N,Belle S,Hofheinz R,Krause A,Schmid RM,Röcken C,Ebert MP

    更新日期:2012-12-10 00:00:00

  • Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference.

    abstract:BACKGROUND:Methyl-CpG binding domain protein 1 (MBD1), a suppressor of gene transcription, may be involved in inactivation of tumor suppressor genes during tumorigenesis. Over-expression of MBD1 has been reported in human pancreatic carcinomas. METHODS:In this study, we established a MBD1-knock-down pancreatic cancer ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-121

    authors: Liu C,Chen Y,Yu X,Jin C,Xu J,Long J,Ni Q,Fu D,Jin H,Bai C

    更新日期:2008-04-29 00:00:00

  • Rapid detection of SMARCB1 sequence variation using high resolution melting.

    abstract:BACKGROUND:Rhabdoid tumors are rare cancers of early childhood arising in the kidney, central nervous system and other organs. The majority are caused by somatic inactivating mutations or deletions affecting the tumor suppressor locus SMARCB1 [OMIM 601607]. Germ-line SMARCB1 inactivation has been reported in associatio...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-437

    authors: Dagar V,Chow CW,Ashley DM,Algar EM

    更新日期:2009-12-13 00:00:00

  • miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.

    abstract:BACKGROUND:MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene expression regulation and have been described as key regulators of carcinogenesis. Aberrant miRNA expression has been frequently reported in sporadic breast cancers, but few studies have focused on profiling hereditary breast ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6640-y

    authors: Pessôa-Pereira D,Evangelista AF,Causin RL,da Costa Vieira RA,Abrahão-Machado LF,Santana IVV,da Silva VD,de Souza KCB,de Oliveira-Silva RJ,Fernandes GC,Reis RM,Palmero EI,Marques MMC

    更新日期:2020-02-22 00:00:00

  • Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial

    abstract:BACKGROUND:Increasing the biological effective dose (BED) of radiotherapy for non-small cell lung cancer (NSCLC) can increase local control rates and improve overall survival. Compared with conventional fractionated radiotherapy, accelerated hypofractionated radiotherapy can yield higher BED, shorten the total treatmen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2314-1

    authors: Ren XC,Wang QY,Zhang R,Chen XJ,Wang N,Liu YE,Zong J,Guo ZJ,Wang DY,Lin Q

    更新日期:2016-04-23 00:00:00